Acta Pharm. 57
(2007) 99-109
Short communication
Liquisolid technique as a tool for the enhancement of poorly water-soluble drugs
and evaluation of their physicochemical properties
YOUSEF JAVADZADEH1, MOHAMMAD
REZA SIAHI1, SOLMAZ ASNAASHARI1 and ALI
NOKHODCHI1,2,*
a.nokhodchi@kent.ac.uk
1Drug Applied Research Center and Faculty of
Pharmacy, Tabriz University of Medical Sciences, Iran
2Medway School of Pharmacy, Central Ave.,
University of Kent and Greenwich, Chatham, Kent, ME4 4TB, United Kingdom
The potential of liquisolid
systems to improve the dissolution properties of a water-insoluble agent
(indomethacin) was investigated. In this study, different formulations of liquisolid tablets using different co-solvents
(non-volatile solvents) were prepared and the effect of aging on the
dissolution behaviour of indomethacin liquisolid compacts was investigated. To evaluate any interaction
between indomethacin and the other components in liquisolid
formulations, X-ray powder
diffraction (XPD) and differential scanning calorimetry
(DSC) were used. Dissolution test was carried out at two different pH, 1.2 and
7.2, to simulate the stomach or intestine fluid, respectively. The results
showed that liquisolid formulations exhibited
significantly higher drug dissolution rates at pH 1.2 and 7.2 compared to
compacts prepared by the direct compression technique. The enhanced rate of
indomethacin dissolution from liquisolid tablets was,
due to an increase in wetting properties and surface area of drug particles available
for dissolution. In order to investigate the effect of aging on the hardness
and dissolution rate of liquisolid compacts, the formulations
were stored at 25 oC/75% relative humidity for a period of 12
months. The results showed that aging had no significant effect on dissolution
profiles of liquisolid tablets. Liquisolid
compacts containing propylene glycol as vehicle produced higher dissolution
rates in comparison with liquisolid compacts
containing PEG 400 or Tween 80 of the same
concentration. The DSC and XPD results showed no changes in crystallinity
of the drug and interaction between indomethacin and excipients
(Avicel and silica) during the process.
Keywords: indomethacin, liquisolid
compacts, dissolution rate, aging, DSC, XPD